Top Journals for Publication in 2025: A Comprehensive Guide

An Academy Guide

Interesting topics

Top Journals for Publication in 2025: A Comprehensive Guide

Table of Content

For researchers seeking to reach a wider audience and increase their academic visibility, publishing in high-impact journals is important. As we enter 2025, selecting the impact factor journals to submit manuscripts to is essential for progressing in science and medical-related research. This guide is designed to find the best journals in different fields (high-impact factor, SCI-indexed, Scopus journals) for 2025.

1. Top Journals for Publication in 2025

High-quality journals provide an opportunity to disseminate original research that brings value to people in the scientific community. High-quality journals endure a rigorous peer-review process and are especially indexed in prestigious databases such as SCI (Science Citation Index) and Scopus.

1.1. Key Features to Look For in Top Journals

Highly reputable impact factor (IF)
Secure peer review
International readership
Includes in well-regarded databases, like SCI and Scopus
Quick publishing response and open access options

2. High-Impact Journals in 2025

High-impact journals are acknowledged for scholarly reputation and ability to shape the direction of their fields. They are the source of the articles that will contribute to key discoveries and trending developments in science.

Examples of High-Impact Journals

Journal Name	Impact Factor	Publisher	Subject Area	Indexed In
Nature [1]	48.5	Springer Nature	Multidisciplinary	SCI, Scopus
The Lancet	88.5	Elsevier	Medicine, Healthcare	SCI, Scopus
Cell [2]	42.5	Elsevier	Life Sciences	SCI, Scopus
JAMA [3]	120.7	American Medical Association	Medical, Clinical	SCI, Scopus
Science	45.8	American Association for the Advancement of Science	Multidisciplinary	SCI, Scopus

3. Best Journals for Manuscript Submission in 2025

When choosing a journal for manuscript submission, factors like speed of publication, ease of submission, and reputation matter. The following journals offer streamlined submission processes, wide visibility, and a broad impact on academic research.

Popular Journals for Manuscript Submission

Popular Journals for Manuscript Submission
Journal Name	Impact Factor	Publisher	Subject Area	Indexed In
Journal of Clinical Investigation (JCI)	15.9	American Society for Clinical Investigation	Clinical Research, Medicine	SCI, Scopus
British Medical Journal (BMJ) [4]	93.7	BMJ Publishing Group	Medicine, Healthcare	SCI, Scopus
PLOS ONE [5]	2.6	Public Library of Science (PLOS)	Multidisciplinary, Medicine	Scopus
IEEE Transactions on Medical Imaging	10.6	IEEE	Medical Imaging, Biomedical Engineering	Scopus

4. SCI-Indexed Journals for 2025

SCI-indexed journals are highly regarded for their contributions to scientific advancement. These journals are included in the SCI, which ensures the credibility and visibility of published research.

Top SCI-Indexed Journals in 2025

Top Journals in Molecular & Infectious Diseases

Journal Name	Impact Factor	Publisher	Subject Area	Indexed In
Nature Reviews Molecular Cell Biology	113.915	Springer Nature	Molecular Biology	SCI
New England Journal of Medicine [6]	78.5	Massachusetts Medical Society	Medicine, Healthcare	SCI
The Lancet Infectious Diseases [7]	31.0	Elsevier	Infectious Diseases	SCI
Cell Stem Cell	20.4	Elsevier	Stem Cell Research	SCI

5. Scopus Journals with High Impact Factor in 2025

Scopus-indexed journals are among the most respected in the academic community. They offer broad visibility and reach across multiple disciplines, helping researchers to make a meaningful impact in their fields.

Notable Scopus Journals for 2025

Lancet Oncology – Elsevier
Nature Reviews Drug Discovery – Springer Nature
Clinical Infectious Diseases – Oxford University Press

6. Top Medical/Scientific Journals to Publish in 2025

Medical and scientific journals remain the cornerstone of knowledge dissemination in healthcare, medicine, and life sciences. Researchers in these fields can aim to publish in these journals to reach a global audience and contribute to the scientific community.

Top Medical Journals:

The Lancet (Impact Factor: 59.891) – Elsevier
JAMA (Impact Factor: 56.272) – American Medical Association
British Medical Journal (Impact Factor: 39.2) – BMJ Publishing Group

Top Scientific Journals:

Science (Impact Factor: 47.728) – American Association for the Advancement of Science
Cell (Impact Factor: 38.637) – Elsevier
Nature (Impact Factor: 42.779) – Springer Nature

Conclusion

In 2025, selecting the right journal for publication is critical to ensuring the impact and visibility of your research. By targeting high-impact, SCI-indexed, and Scopus journals, you increase the likelihood that your work will be disseminated widely and have a lasting impact on your field. These journals not only offer credibility but also provide a platform for advancing scientific knowledge, improving clinical practice, and shaping public policy. Always choose a journal that aligns with your research focus, impact goals, and publication needs.

References

Mastrangelo, A., Robles-Vera, I., Mañanes, D., Galán, M., Femenía-Muiña, M., Redondo-Urzainqui, A., Barrero-Rodríguez, R., Papaioannou, E., Amores-Iniesta, J., Devesa, A., Lobo-González, M., Carreras, A., Beck, K. R., Ivarsson, S., Gummesson, A., Georgiopoulos, G., Rodrigo-Tapias, M., Martínez-Cano, S., Fernández-López, I., … Sancho, D. (2025). Imidazole propionate is a driver and therapeutic target in atherosclerosis. Nature. https://doi.org/10.1038/s41586-025-09263-w
Li, W., Yang, K., Hu, C., Abbas, W., Zhang, J., Xu, P., Cheng, B., Zhang, J., Yin, W., Shalmani, A., Qu, L., Lv, Q., Li, B., He, Y., Lai, X., Xiong, L., Zhang, Q., & Li, Y. (2025). A natural gene on-off system confers field thermotolerance for grain quality and yield in rice. Cell. https://doi.org/10.1016/j.cell.2025.06.041
Forrest, C. B., Koenigsberg, L. J., Eddy Harvey, F., Maltenfort, M. G., & Halfon, N. (2025). Trends in US children’s mortality, chronic conditions, obesity, functional status, and symptoms. JAMA: The Journal of the American Medical Association. https://doi.org/10.1001/jama.2025.9855
Roland, N., Kolla, E., Baricault, B., Dayani, P., Duranteau, L., Froelich, S., Zureik, M., & Weill, A. (2025). Oral contraceptives with progestogens desogestrel or levonorgestrel and risk of intracranial meningioma: national case-control study. BMJ (Clinical Research Ed.), 389, e083981. https://doi.org/10.1136/bmj-2024-083981
Vialle, M., Saias-Magnan, J., Dezamis, A., Guillemain, C., Bouhnik, A.-D., Mancini, J., & Courbiere, B. (2025). Exploring fertility preservation in AYA cancer survivors: Information needs and post-cancer challenges. PloS One, 20(5), e0323867. https://doi.org/10.1371/journal.pone.0323867
Hyslop, L. A., Blakely, E. L., Aushev, M., Marley, J., Takeda, Y., Pyle, A., Moody, E., Feeney, C., Dutton, J., Shaw, C., Smith, S. J., Craig, K., Alston, C. L., Lister, L., Endacott, K., Byerley, S., McDermott, H., Wilson, K., Botham, L., … Herbert, M. (2025). Mitochondrial donation and preimplantation genetic testing for mtDNA disease. The New England Journal of Medicine, NEJMoa2415539. https://doi.org/10.1056/nejmoa2415539
Weinstein, E., Paredes, R., Gardner, A., Almas, M., Baniecki, M. L., Guan, S., Tudone, E., Antonucci, S., Gregg, K., Garcia-Vidal, C., Camacho-Ortiz, A., Wisemandle, W., Terra, S. G., Liu, S., Aberg, J. A., Rana, M. M., Corey, L., Ford, E. S., Hammond, J., & Rusnak, J. (2025). Extended nirmatrelvir–ritonavir treatment durations for immunocompromised patients with COVID-19 (EPIC-IC): a placebo-controlled, randomised, double-blind, phase 2 trial. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(25)00221-x